Biomex GmbH was founded by Mr Gerhard Held in 1989. In its early years, it supplied primarily diagnostic product manufacturers with biological and biochemical raw materials such as blood plasma and bovine serum albumin. At the time of founding, Mr Held already had 15 years of professional experience as a supplier of special raw materials.

On his 70th birthday, Mr Held decided to put Biomex GmbH’s destiny into younger hands. Since 01/07/2004, Mr Oliver Bošnjak, who holds degrees in chemistry and business, has been the managing director of Biomex GmbH. At the time the business changed hands, it was also moved from Mannheim to Heidelberg.

Certification of Biomex GmbH in accordance with DIN EN ISO 9001:2000.

Foundation of the plasma centre in Munich for the production of plasma for diagnostic purposes with a focus on the production of disease state plasmas (HIV, HCV, HBV, Toxo, CMV, Rubella). Certification of the plasma centre in accordance with ISO 9001: 2000. Staff of 10 employees.

Expansion of the plasma centre to produce specific normal plasma for the diagnostic industry. The production capacity is 25,000 litres p.a. The range of plasmas is added to in the areas of haemostasis plasmas (Coumadin, F VIII, Di-Dimer, Factor V Leiden and many others) and tropical diseases. Staff of 20 employees.

Successful ISO 9001: 2000 recertification. Purchase of a 1200m2 company building. Construction of a company laboratory. Staff of 30 employees.

Taking over of SeroConversion Panel of Life Therapeutics USA. Taking over of the assets of the SeroLife Company, Swiss. Divestment of the plasma centre in Munich to the Transfusioninstitute Synlab Ltd. Contemporaneous opening of the plasma centre in Munich for special plasmas. Start-up of the plasma centre in Heidelberg (www.plasmazentrum–heidelberg.de) for the manufacturing of plasmas for diagnostic purposes. (Negative plasmas with an annual capacity of 25.000 litre, special plasma).

Expansion of the facilities. Enlargement of the laboratory to 110 m². Permission for a microbiological laboratory (L2-lab according to DIN 58956-3). Purchase of several infectiological testsystems. Certification according to DIN EN ISO 13485:2003. Recertification according to DIN EN ISO 9001:2008.

Enlargement of the laboratory and cooling capacity. Creation of a donor center for patient samples in Western Africa. Certification of Biomex according to DIN EN ISO 13485:2003.

Enlargement of the production capacity by 120 m². Foundation of the DiaMex GmbH as affiliate company selling manufacturer independent third party controls. Purchase of several infectiological test systems.

Enlargement of the laboratory and lab equipment. Five more employees hired. First participation at the MEDICA.

Foundation of a subsidiary in the USA (Biomex US LLC). New in the portfolio: CTS panel and studies for the approval of IvD products (list A, B and others). Start of sales in China through sales partner. First participation at the AACC. Employment of the 60th employee.

More space and new design of the booth at the MEDICA. New in the portfolio: Prospective Clinical Collection.
Employment of the 70th employee.

First participation at the Arab Health in Dubai.